Gene: PRICKLE2

166336
EPM5
prickle planar cell polarity protein 2
protein-coding
3p14.1
Ensembl:ENSG00000163637 MIM:608501 Vega:OTTHUMG00000158789 UniprotKB:Q7Z3G6
NG_031930.1
SNP Mapped
ND
0   
NA (AD)  NA (ND)   (Frontal_Cortex)
7.845e-1 (AD)  7.884e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs201013261chr3:64125982-64125983 (GRCh38.p7)insACnicotine dependenceInsertion
rs1024895chr3:64125982 (GRCh38.p7)T>Cnicotine dependenceSNV(Single Nucleotide Variation)
rs830010chr3:64123061 (GRCh38.p7)C>Anicotine dependenceSNV(Single Nucleotide Variation)
rs1096170chr3:64118712 (GRCh38.p7)C>Tnicotine dependenceSNV(Single Nucleotide Variation)

DNA Methylation

Probe Locus(GRCh37) Gene Region p-val Trait PubMed ID
cg18450254chr3:64200005PRICKLE22.300e-21Smoking27651444

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
CSRNP20.93
CCSAP0.928
TBPL10.92
NEDD4L0.914
DCAF100.912
FEM1B0.912
ARHGEF70.911
KAT70.91
CCDC60.909
AFTPH0.909

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.544
OR4F29-0.496
ASB4-0.439
TFPI2-0.436
KLRB1-0.419
FZD10-0.405
KLRF1-0.395
MYL3-0.393
IL18RAP-0.39
CSAG1-0.389

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0127962-butenal2-butenal results in decreased expression of PRICKLE2 mRNA20471460
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRICKLE2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRICKLE2 mRNA"27188386
D000082AcetaminophenAcetaminophen results in decreased expression of PRICKLE2 mRNA29067470
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of PRICKLE2 mRNA27153756
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased mutagenesis of PRICKLE2 gene25435355
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of PRICKLE2 mRNA21839799
C006780bisphenol Abisphenol A affects the expression of PRICKLE2 mRNA21786754
C006780bisphenol Abisphenol A results in increased expression of PRICKLE2 mRNA29275510
C006780bisphenol A[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PRICKLE2 mRNA28628672
C006780bisphenol Abisphenol A affects the expression of PRICKLE2 mRNA21786754
C006780bisphenol Abisphenol A results in decreased expression of PRICKLE2 mRNA25181051
C006780bisphenol Abisphenol A results in increased methylation of PRICKLE2 gene28505145
C000611646bisphenol F[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PRICKLE2 mRNA28628672
D004390ChlorpyrifosChlorpyrifos results in increased expression of PRICKLE2 mRNA21356183
D003042CocaineCocaine results in increased expression of PRICKLE2 mRNA17898221
D003471CuprizoneCuprizone results in decreased expression of PRICKLE2 mRNA26577399
D016572CyclosporineCyclosporine results in decreased expression of PRICKLE2 mRNA20106945|2798913
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PRICKLE2 mRNA28628672
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PRICKLE2 mRNA28628672
D002945Cisplatin[Cisplatin co-treated with jinfukang] results in decreased expression of PRICKLE2 mRNA27392435
D002945CisplatinCisplatin results in decreased expression of PRICKLE2 mRNA27392435
D002117CalcitriolCalcitriol results in decreased expression of PRICKLE2 mRNA16002434
C045651epigallocatechin gallateepigallocatechin gallate results in increased expression of PRICKLE2 mRNA22079256
C045651epigallocatechin gallate[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PRICKLE2 mRNA22079256
D005020Ethyl MethanesulfonateEthyl Methanesulfonate results in increased expression of PRICKLE2 mRNA23649840
D005557FormaldehydeFormaldehyde results in increased expression of PRICKLE2 mRNA23649840
C039281furanfuran results in increased methylation of PRICKLE2 gene22079235
D017313FenretinideFenretinide results in increased expression of PRICKLE2 mRNA28973697
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PRICKLE2 mRNA28628672
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PRICKLE2 mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PRICKLE2 mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PRICKLE2 mRNA28628672
C544151jinfukang[Cisplatin co-treated with jinfukang] results in decreased expression of PRICKLE2 mRNA27392435
C544151jinfukangjinfukang results in decreased expression of PRICKLE2 mRNA27392435
D007854LeadLead affects the expression of PRICKLE2 mRNA28903495
D008070LipopolysaccharidesLipopolysaccharides results in decreased methylation of PRICKLE2 gene21212295
D008070Lipopolysaccharides[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of PRICKLE2 gene21212295
D008070Lipopolysaccharides[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of PRICKLE2 gene21212295
D008748MethylcholanthreneMethylcholanthrene results in decreased expression of PRICKLE2 mRNA20713471
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in increased expression of PRICKLE2 mRNA23649840
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of PRICKLE2 mRNA"25554681
C030110oxaliplatin[oxaliplatin co-treated with Topotecan] results in increased expression of PRICKLE2 mRNA25729387
C030110oxaliplatinoxaliplatin results in increased expression of PRICKLE2 mRNA25729387
D052638Particulate MatterParticulate Matter results in decreased expression of PRICKLE2 mRNA22178795
D010634PhenobarbitalPhenobarbital affects the methylation of PRICKLE2 gene19233941
D010634PhenobarbitalPhenobarbital affects the methylation of PRICKLE2 promoter19482888
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRICKLE2 mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in increased expression of PRICKLE2 mRNA26272509
C027373potassium chromate(VI)[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PRICKLE2 mRNA22079256
C027373potassium chromate(VI)potassium chromate(VI) results in decreased expression of PRICKLE2 mRNA22079256|2271453
D011192Potassium DichromatePotassium Dichromate results in increased expression of PRICKLE2 mRNA23608068
D011285Pregnenolone CarbonitrilePregnenolone Carbonitrile results in decreased expression of PRICKLE2 mRNA19162173
D011441PropylthiouracilPropylthiouracil results in increased expression of PRICKLE2 mRNA24780913
C513635S-2-pentyl-4-pentynoic hydroxamic acidS-2-pentyl-4-pentynoic hydroxamic acid results in increased expression of PRICKLE2 mRNA21427059
D012643SeleniumSelenium results in decreased methylation of PRICKLE2 gene21606628
D012822Silicon DioxideSilicon Dioxide analog results in decreased expression of PRICKLE2 mRNA25895662
C009277sodium arsenatesodium arsenate results in increased expression of PRICKLE2 mRNA21795629
D014284TriiodothyronineTriiodothyronine results in decreased expression of PRICKLE2 mRNA25172293
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of PRICKLE2 gene21212295
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of PRICKLE2 gene21212295
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased methylation of PRICKLE2 gene21212295
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased methylation of PRICKLE2 gene21212295
C009495titanium dioxidetitanium dioxide results in decreased expression of PRICKLE2 mRNA23557971
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in decreased expression of PRICKLE2 mRNA28065790
D019772Topotecan[oxaliplatin co-treated with Topotecan] results in increased expression of PRICKLE2 mRNA25729387
D019772TopotecanTopotecan results in increased expression of PRICKLE2 mRNA25729387
D014212TretinoinTretinoin results in increased expression of PRICKLE2 mRNA20488242
C012589trichostatin Atrichostatin A results in increased expression of PRICKLE2 mRNA24935251
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of PRICKLE2 mRNA"26179874
D014635Valproic AcidValproic Acid affects the expression of PRICKLE2 mRNA25979313
D014635Valproic AcidValproic Acid results in decreased expression of PRICKLE2 mRNA29154799
D014635Valproic AcidValproic Acid results in increased expression of PRICKLE2 mRNA23179753|2800136
D014635Valproic AcidValproic Acid results in increased expression of PRICKLE2 mRNA21427059
D014638VanadatesVanadates results in increased expression of PRICKLE2 mRNA22714537

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0008270zinc ion binding-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0060071Wnt signaling pathway, planar cell polarity pathway-NAS24431302  
GO ID GO Term Qualifier Evidence PubMed
GO:0005737cytoplasm-IDA-  
GO:0031965nuclear membrane-IEA-  
KEGG ID KEGG Term
hsa04310Wnt signaling pathway
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal